Antimicrobials · Penicillins
The facts most likely to be tested
Press 1–5 to rate · ↑↓ to navigate
Amoxicillin is the first-line treatment for acute otitis media in pediatric patients.
Amoxicillin is the drug of choice for the treatment of Group A Streptococcus pharyngitis to prevent rheumatic fever.
Amoxicillin is a component of the triple therapy regimen used for the eradication of Helicobacter pylori.
Amoxicillin is the preferred prophylaxis for infective endocarditis in patients undergoing high-risk dental procedures.
Amoxicillin administration in patients with Epstein-Barr virus (EBV) infection frequently results in a maculopapular rash.
Amoxicillin acts by binding to penicillin-binding proteins (PBPs) to inhibit bacterial cell wall synthesis.
Amoxicillin is often combined with clavulanate to provide coverage against beta-lactamase-producing organisms.
Vignette unlocked
A 5-year-old boy is brought to the clinic by his mother due to a 3-day history of fever and ear pain. Physical examination reveals an erythematous, bulging tympanic membrane with decreased mobility on pneumatic otoscopy. The child has no known drug allergies. His mother reports he recently recovered from a viral upper respiratory infection.
What is the most appropriate first-line pharmacotherapy for this patient?
Amoxicillin
The patient presents with classic signs of acute otitis media, for which high-dose amoxicillin is the first-line treatment of choice per current clinical guidelines.
Full handout
High yield triage
Classification
Aminopenicillin; beta-lactam antibiotic.
Indications
Acute otitis media, streptococcal pharyngitis, and H. pylori eradication.
Mechanism of Action
Inhibits transpeptidase; prevents peptidoglycan cross-linking.
Side Effects
Diarrhea, nausea, anaphylaxis, maculopapular rash.
Contraindications / Monitoring
History of IgE-mediated penicillin allergy. Monitor renal function in elderly.
Full handout
Mechanism of Action
Amoxicillin binds to penicillin-binding proteins (PBPs), inhibiting the final stage of bacterial cell wall synthesis. By blocking transpeptidase enzymes, it prevents the cross-linking of peptidoglycan chains. This leads to cell wall instability and subsequent bacteriolysis. It is effective against susceptible organisms but is susceptible to hydrolysis by beta-lactamases.
Unique Properties
Amoxicillin offers superior oral bioavailability compared to ampicillin, allowing for less frequent dosing. It provides broader gram-negative coverage than natural penicillins, specifically targeting H. influenzae and E. coli. It is often combined with clavulanate to overcome resistance mediated by beta-lactamase production.
Indications
It is the first-line treatment for acute otitis media in children. It is also the drug of choice for streptococcal pharyngitis and is a core component of the triple therapy regimen for H. pylori infection. Additionally, it is used for prophylaxis of infective endocarditis in high-risk patients undergoing dental procedures.
Pharmacokinetics
Amoxicillin is well-absorbed orally and is not significantly affected by food intake. It is primarily excreted unchanged via the kidneys through glomerular filtration and tubular secretion. Dosage adjustments are required in patients with severe renal impairment to prevent accumulation.
Side Effects & Adverse Events
Common adverse effects include diarrhea, nausea, and vomiting. A non-allergic maculopapular rash frequently occurs in patients with mononucleosis. Serious reactions include anaphylaxis, Clostridioides difficile-associated diarrhea, and rare cases of interstitial nephritis.
Contraindications
The primary contraindication is a history of IgE-mediated hypersensitivity (e.g., anaphylaxis, urticaria) to any penicillin. Caution is advised in patients with a history of severe cephalosporin allergy due to potential cross-reactivity. It should be used with extreme caution in patients with severe renal failure.
Monitoring
Monitor for signs of hypersensitivity, including urticaria or wheezing, during the initial dose. In patients with pre-existing renal insufficiency, monitor serum creatinine and BUN levels. Assess for persistent diarrhea to rule out C. difficile infection.
Clinical Pearls
Boards love the mononucleosis trap: a patient treated for 'strep throat' with amoxicillin who develops a diffuse rash likely has EBV. Remember that amoxicillin is NOT effective against MRSA or organisms producing beta-lactamase unless paired with a beta-lactamase inhibitor.